LNP-RNA Therapeutics – Beyond COVID Symposium
The Controlled Release Society (CRS) is running a 2‑Day Virtual Symposium on April 6th & 7th, 2022. This LNP-RNA Therapeutics – Beyond COVID Symposium will focus on the hugely exciting prospect to build on the progress made in lipid nanoparticle and mRNA technologies during the pandemic.
Many companies now have proven platforms, improved technologies, and more robust supply chains. The opportunity now is to look at where we go next in developing and applying this breakthrough technology beyond COVID-19 vaccines.
This symposium aims to bring together a wide selection of speakers from industry leaders as well as emerging start-ups with exciting new technologies and approaches. A fresh range of voices and perspectives will provide a unique programme for those already working in the field and those interested to learn about this high growth area of medicine.
The symposium will include sessions on:
o Therapeutics and Clinical Translation
o Future in RNA and LNP design
o Improved in in vitro and in vivo methods to support RNA Therapeutic development
o Advanced manufacturing and new technologies
o CAR cell therapies ex vivo/in vivo
o Genome editing
o Unmet patient and clinical needs as well as regulatory challenges